Company profile
EpiEndo Pharmaceuticals company profile
EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of a number of major diseases. Epithelial cells are a key component of the barrier that makes up human skin and lung tissue, as well as the intestinal tract and genitalia. Compromised integrity of this barrier is implicated in the progression and non-resolution of inflammation. EpiEndo is developing a proprietary portfolio of orally available macrolide drug candidates with promise as first-in-class disease-modifying therapeutics, to address the huge global burden of..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.epiendo.com/
- Contact email
- [email protected]
- Phone number
- 00 354 454 0090
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2014-01-01
Headquarters
- Headquarters
- Reykjavík, Capital Region, Iceland
- Postal code
- 170
- Country code
- IS
- Continent
- Europe